Advertisement
Organisation › Details
Verogen Inc.
Verogen is a dedicated developer of DNA-based biometric human identification products for analysis of forensic genomic samples. Working closely with the forensic community, Verogen places exceptional value on flexible, scalable solutions that deliver reliable results. *
Start | 2017-01-01 established | |
Group | Qiagen (Group) | |
Industry | forensics | |
Industry 2 | GEDmatch database and GEDmatch PRO™ portal | |
Person | Williams, Brett (Verogen 202301 CEO) | |
Region | San Diego, CA | |
Country | United States (USA) | |
Street | 11111 Flintkote Avenue | |
City | 92121 San Diego, CA | |
Tel | +1-858-285-4101 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
Currency | USD | |
Annual sales | 20,000,000 (sales, annual, expected (2023) 2023-12-31) | |
* Document for »About Section«: Qiagen N.V.. (1/9/23). "Press Release: Qiagen Completes Acquisition of Verogen, Strengthening Leadership in Human ID / Forensics with NGS Technologies". Venlo & San Diego, CA. | ||
Record changed: 2023-01-11 |
Advertisement
More documents for Qiagen (Group)
- [1] Qiagen N.V.. (9/18/24). "Press Release: Qiagen Expands QIAcuity Digital PCR Offering with over New 100 Assays via GeneGlobe Platform". Venlo....
- [2] Qiagen N.V.. (9/12/24). "Press Release: Qiagen and Bio-Manguinhos/Fiocruz Collaborate to Enhance Malaria and Dengue Detection in Brazil’s National Screening Programs". Venlo & Rio de Janeiro....
- [3] Qiagen N.V.. (9/4/24). "Press Release: Qiagen and Lilly Collaborate to Support Development of a QIAstat-Dx IVD Panel that Identifies Patients at Risk for Developing Alzheimer’s disease". Venlo....
- [4] Qiagen N.V.. (9/3/24). "Press Release: Qiagen N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds [not for US, CA, AU, JP, ZA, et al.]". Venlo....
- [5] Evotec SE. (6/3/24). "Press Release: Evotec and Qiagen Enter Software Collaboration for Enhanced Multi-omics Data Insights". Hamburg & Venlo....
- [6] Qiagen N.V.. (1/4/24). "Press Release: Qiagen to Accelerate Investments into Qiagen Digital Insights Bioinformatics Business". Venlo....
- [7] Qiagen N.V.. (9/25/23). "Press Release: Qiagen Enhances QIAwave Portfolio with New Eco-friendlier Nucleic Acid Extraction Kits". Venlo....
- [8] Qiagen N.V.. (9/11/23). "Press Release: Qiagen Launches API to Streamline Access to World-leading Biomedical Data for AI Integration". Venlo & Redwood City, CA....
- [9] Qiagen N.V.. (8/8/23). "Press Release: Qiagen Delivers Ahead of Outlook for Q2 2023 with 9% CER Sales Growth in Non-COVID Products and Updates 2023 Full-year Outlook". Venlo....
- [10] Qiagen N.V.. (8/7/23). "Press Release: Qiagen Receives FDA Approval for Companion Diagnostic to Blueprint Medicines’ Ayvakit (avapritinib) in Gastrointestinal Stromal Tumors". Venlo & Germantown, MD....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top